METHICILLIN-RESISTANT STAPHYLOCOCCI PREVALENCE IN CANCER PATIENTS AT A TERTIARY CARE CANCER CENTRE – A RETROSPECTIVE STUDY

Authors

  • SARAVANAN MURUGESAN Division of Microbiology, Department of Clinical Laboratory Services and Translational Research (CLS & TR), Malabar Cancer Centre, Thalassery, Kannur, Kerala, India.
  • SUJINA TK Palayad Campus, Kannur University, Kerala, India.
  • SAJANI SAMUEL Division of Microbiology, Department of Clinical Laboratory Services and Translational Research (CLS & TR), Malabar Cancer Centre, Thalassery, Kannur, Kerala, India.
  • SARATH KE Division of Microbiology, Department of Clinical Laboratory Services and Translational Research (CLS & TR), Malabar Cancer Centre, Thalassery, Kannur, Kerala, India.
  • PARTHIBAN RUDRAPATHY Division of Microbiology, Department of Clinical Laboratory Services and Translational Research (CLS & TR), Malabar Cancer Centre, Thalassery, Kannur, Kerala, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i7.41482

Keywords:

Methicillin-resistant staphylococci, Prevalence, Antibiotic, Antibiotic resistanc, Cancer patients

Abstract

Objective: The objective of this study was to investigate the prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) and MR-coagulase-negative staphylococci (CoNS), as well as their antimicrobial resistance, in various samples from cancer patients in North Kerala.

Methods: The retrospective study was conducted at a tertiary care cancer centre in North Kerala over a 4-year period from January 2016 to December 2019. During the study, data on all cultures from cancer patients was analyzed. This study was approved by Institutional Review Board (IRB). Non-duplicate isolates of staphylococci were included in the study obtained from various clinical specimens. Species identification and antimicrobial susceptibility testing was done using automated methods.

Results: During the period of 4 years (2016–2019), a total of 1176 isolates of staphylococci were analyzed, out of which 784 were S. aureus isolates (68%) and 392 (32%) isolates were CoNS. Among CoNS species, Staphylococcus epidermidis and Staphylococcus haemolyticus were the most common species of CoNS, representing 39% and 28% of the total CoNS identified. Overall prevalence of methicillin resistance in S. aureus and CoNS was found to be 50.7% and 55.6%, respectively. Methicillin-resistant staphylococci isolates showed higher resistance to multiple drugs than methicillin-sensitive staphylococci isolates.

Conclusion: This study demonstrates that MRS could also be a haul in cancer patients at North Kerala. A higher percentage of MR-CoNS isolates are multidrug resistant than MRSA isolates. Glycopeptides and linezolid still stay the mainstay for treatment for MRS infections.

Downloads

Download data is not yet available.

References

Bhat V, Gupta S, Kelkar R, Biswas S, Khattry N, Moiyadi A, et al. Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center. Indian J Med Paediatr Oncol 2016;37:20-4. DOI: https://doi.org/10.4103/0971-5851.177010

El-Gendy MM, El-Bondkly AM, Keera AA, Ali AM. Incidence of methicillin resistant Staphylococcus aureus (MRSA) in microbial community of cancer patients and evaluation of their resistant pattern. Arab J Sci Eng 2017;43:83-92. DOI: https://doi.org/10.1007/s13369-017-2670-4

Kitti T, Seng R, Saiprom N, Thummeepak R, Chantratita N, Boonlao C, et al. Molecular characteristics of methicillin-resistant staphylococci clinical isolates from a tertiary Hospital in Northern Thailand. Can J Infect Dis Med Microbiol 2018;2018:8457012. DOI: https://doi.org/10.1155/2018/8457012

Becker K, Both A, Weißelberg S, Heilmann C, Rohde H. Emergence of coagulase-negative staphylococci. Expert Rev Anti Infect Ther 2020;18:349-6. DOI: https://doi.org/10.1080/14787210.2020.1730813

Montazeri EA, Seyed-Mohammadi S, Dezfuli AA, Khosravi AD, Dastoorpoor M, Roointan M, et al. Investigation of SCCmec types I-IV in clinical isolates of methicillin-resistant coagulase-negative staphylococci in Ahvaz, Southwest Iran. Biosci Rep 2020;40:BSR20200847. DOI: https://doi.org/10.1042/BSR20200847

Nanoukon C, Argemi X, Sogbo F, Orekan J, Keller D, Affolabi D, et al. Pathogenic features of clinically significant coagulase-negative staphylococci in hospital and community infections in Benin. Int J Med Microbiol 2017;307:75-82. DOI: https://doi.org/10.1016/j.ijmm.2016.11.001

McManus BA, Coleman DC, Deasy EC, Brennan GI, O’Connell B, Monecke S, et al. Comparative genotypes, staphylococcal cassette chromosome mec (SCCmec) genes and antimicrobial resistance amongst Staphylococcus epidermidis and Staphylococcus haemolyticus isolates from infections in humans and companion animals. PLoS One 2015;10:e0138079. DOI: https://doi.org/10.1371/journal.pone.0138079

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Vol. 30. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.

Murugesan S, Perumal N, Dass BS, Vijayakumar R, Krishnan P. Prevalence and molecular characterisation of methicillin-resistant coagulase negative staphylococci (MR-CoNS) isolated from nasal carriers of end stage renal disease patients-a prospective study. J Clin Diagn Res 2019;13:DC10-5. DOI: https://doi.org/10.7860/JCDR/2019/40266.12888

Bora P, Datta P, Gupta V, Singhal L, Chander J. Characterization and antimicrobial susceptibility of coagulase-negative staphylococci isolated from clinical samples. J Lab Physicians 2018;10:414-9. DOI: https://doi.org/10.4103/JLP.JLP_55_18

Rajkumar S, Sistla S, Manoharan M, Sugumar M, Nagasundaram N, Parija SC, et al. Prevalence and genetic mechanisms of antimicrobial resistance in Staphylococcus species: A multicentre report of the Indian council of medical research antimicrobial resistance surveillance network. Indian J Med Microbiol 2017;35:53-60. DOI: https://doi.org/10.4103/ijmm.IJMM_16_427

Abimannan N, Sumathi G, Krishnarajasekhar OR, Sinha B, Krishnan P. Clonal clusters and virulence factors of methicillin-resistant Staphylococcus aureus: Evidence for community-acquired methicillin-resistant Staphylococcus aureus infiltration into hospital settings in Chennai, South India. Indian J Med Microbiol 2019;37:326-36. DOI: https://doi.org/10.4103/ijmm.IJMM_18_271

Singh L, Cariappa MP, Das NK. Drug sensitivity pattern of various Staphylococcus species isolated at a tertiary care hospital. Med J Armed Forces India 2016;72:S62-6. DOI: https://doi.org/10.1016/j.mjafi.2016.07.009

Indian Network for Surveillance of Antimicrobial Resistance (INSAR) group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence and susceptibility pattern. Indian J Med Res 2013;137:363-9.

Ghosh S, Banerjee M. Methicillin resistance and inducible clindamycin resistance in Staphylococcus aureus. Indian J Med Res 2016;143:362-4. DOI: https://doi.org/10.4103/0971-5916.182628

Mamtora D, Saseedharan S, Bhalekar P, Katakdhond S. Microbiological profile and antibiotic susceptibility pattern of gram-positive isolates at a tertiary care hospital. J Lab Physicians 2019;11:144-8. DOI: https://doi.org/10.4103/JLP.JLP_173_18

Garoy EY, Gebreab YB, Achila OO, Tekeste DG, Kesete R, Ghirmay R, et al. Methicillin-resistant Staphylococcus aureus (MRSA): Prevalence and antimicrobial sensitivity pattern among patients a multicenter study in Asmara, Eritrea. Can J Infect Dis Med Microbiol 2019;2019:8321834. DOI: https://doi.org/10.1155/2019/8321834

Mama M, Aklilu A, Misgna K, Tadesse M, Alemayehu E. Methicillin-and inducible clindamycin-resistant Staphylococcus aureus among patients with wound infection attending Arba Minch hospital, South Ethiopia. Int J Microbiol 2019:2965490. DOI: https://doi.org/10.1155/2019/2965490

Chinnambedu RS, Marimuthu RR, Sunil SS, Amrose P, Ramachandran V, Pachamuthu B. Changing antibiotic resistance profile of Staphylococcus aureus isolated from HIV patients (2012-2017) in Southern India. J Infect Public Health 2020;13:75-9. DOI: https://doi.org/10.1016/j.jiph.2019.06.015

Veeraraghavan B, Walia K. Antimicrobial susceptibility profile and resistance mechanisms of global antimicrobial resistance surveillance system (GLASS) priority pathogens from India. Indian J Med Res 2019;149:87-96. DOI: https://doi.org/10.4103/ijmr.IJMR_214_18

Published

07-07-2021

How to Cite

MURUGESAN, S., S. TK, S. SAMUEL, S. KE, and P. RUDRAPATHY. “METHICILLIN-RESISTANT STAPHYLOCOCCI PREVALENCE IN CANCER PATIENTS AT A TERTIARY CARE CANCER CENTRE – A RETROSPECTIVE STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 14, no. 7, July 2021, pp. 82-85, doi:10.22159/ajpcr.2021.v14i7.41482.

Issue

Section

Original Article(s)